相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
Jose Maria Piulats et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
Meredith S. Pelster et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Uveal melanoma
Martine J. Jager et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma
Mark R. Middleton et al.
CLINICAL CANCER RESEARCH (2020)
A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM)
J. J. Sacco et al.
ANNALS OF ONCOLOGY (2020)
Clinical predictors of survival in metastatic uveal melanoma
Daniel Lorenzo et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2019)
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
L. Khoja et al.
ANNALS OF ONCOLOGY (2019)
Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours
Kate L. Lowe et al.
CANCER TREATMENT REVIEWS (2019)
Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types
Monique K. van der Kooij et al.
CANCERS (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis
Elina S. Rantala et al.
MELANOMA RESEARCH (2019)
Metastatic disease from uveal melanoma: treatment options and future prospects
Richard D. Carvajal et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells
Caroline Boudousquie et al.
IMMUNOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Management of uveal melanoma: a consensus-based provincial clinical practice guideline
E. Weis et al.
CURRENT ONCOLOGY (2016)
ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells
Giovanna Bossi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Multiple Testing in Group Sequential Trials Using Graphical Approaches
Willi Maurer et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2013)
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Kristina Buder et al.
CANCER MEDICINE (2013)
Monoclonal TCR-redirected tumor cell killing
Nathaniel Liddy et al.
NATURE MEDICINE (2012)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Very long-term prognosis of patients with malignant uveal melanoma
E Kujala et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
分享论文
